This test is most useful if any of these apply to you.
Bartonella quintana is the bacterium behind trench fever, an infection most famous from the trenches of World War I but still circulating today, especially among people exposed to body lice, unstable housing, or close contact with stray cats. When your body first encounters it, the immune system pumps out an early-response antibody called IgM, which can show up in your blood within days to weeks of infection.
A positive B. quintana IgM (Bartonella quintana immunoglobulin M) result can flag a recent or active infection that standard blood cultures often miss, since this organism is notoriously hard to grow in the lab. A negative result is not a clean bill of health, but in the right clinical setting, a positive IgM combined with symptoms is one of the earliest signs that something serious may be brewing.
IgM is the first class of antibody your immune system makes when it sees a new threat. For B. quintana, IgM typically rises in the acute phase of infection and then declines over weeks as your body shifts production to IgG (immunoglobulin G), a longer-lasting antibody that signals ongoing or past exposure. A documented case showed exactly this pattern: B. quintana IgM at a titer of 1:256 with undetectable IgG during acute illness, then five weeks later IgM was gone and IgG appeared at 1:64.
This is why IgM is treated as a marker of recent or active disease, while IgG points more toward past or chronic exposure. The two together tell a story about where you are in the infection.
The most serious thing B. quintana can do to you is cause endocarditis, an infection of the heart valves that often grows quietly over months. It is one of the leading culprits behind blood culture-negative endocarditis, meaning standard cultures come back clean even though infection is destroying valve tissue.
Here is the catch: by the time endocarditis is established, IgM is usually gone. In an Iranian series of 50 surgical patients with blood culture-negative endocarditis, every single patient tested negative for Bartonella IgM, even the one with PCR-confirmed B. quintana on the valve. That patient had high IgG instead. So IgM is most useful early, before chronic infection sets in, and a negative IgM in someone with a longstanding heart murmur does not rule out the disease.
It can feel contradictory that a single biomarker is helpful in some B. quintana infections and useless in others. The resolution is timing. IgM is an acute-phase signal. It catches the early window of infection but disappears as the immune response matures. In long-standing infections like valve endocarditis, the body has already finished its IgM phase and switched to IgG. IgM negative does not mean infection negative; it means whatever is happening is either recent (and IgM has not yet appeared), already chronic (and IgM has faded), or not B. quintana at all. Reading IgM correctly requires knowing roughly how long symptoms have been present.
B. quintana can also show up as a vasculitic rash, where small blood vessels in the skin become inflamed. A documented acute infection with a leucocytoclastic vasculitis rash was caught with a positive B. quintana IgM (1:256) while IgG was still negative. After two weeks of doxycycline, the fever broke within 36 hours and the patient fully recovered. This is one of the situations where catching IgM early can directly change the course of illness.
B. quintana can also cause bacteremia, meaning live bacteria circulating in the bloodstream, often presenting as unexplained fever that comes and goes. In a study of 1,922 patients with persistent febrile illness across Cambodia, Nepal, Sudan, and the Democratic Republic of Congo, 16.6% of cases were tied to either Coxiella burnetii or Bartonella species infections. This is a meaningful slice of fever cases that get missed when only routine workups are done.
Bartonella serology has known weaknesses, and one IgM reading taken in isolation can mislead in several ways. The most important issues come from how the test cross-reacts and from the natural timing of antibody production.
A single antibody titer is a snapshot, not a story. The most reliable serologic evidence of active infection is a four-fold rise in titer between an acute sample and one drawn two to four weeks later, or a clear shift from IgM-positive/IgG-negative to IgM-negative/IgG-positive over weeks. If you have an initial positive IgM, retesting in 2 to 6 weeks helps confirm whether your immune system is responding to a real infection or whether the first reading was background noise or cross-reactivity.
If symptoms are ongoing and your first IgM was negative, a repeat test in 1 to 2 weeks may catch the antibody rise that had not yet happened. Serial testing matters here far more than any single number.
If your B. quintana IgM comes back positive, do not stop with one test. The next steps depend on your symptoms and risk factors:
A negative IgM in someone with high clinical suspicion is not a stopping point either. If symptoms persist, push for IgG testing, PCR on blood or biopsied tissue, and specialist input. The combination of clinical picture, multiple antibody classes, and molecular testing carries far more weight than any single result.
Evidence-backed interventions that affect your B. Quintana Antibody IgM Screen level
B. Quintana Antibody IgM Screen is best interpreted alongside these tests.
B. Quintana Antibody IgM Screen is included in these pre-built panels.